ArticleJournal of thoracic disease2025
Impact of preoperative left ventricular diastolic dysfunction on primary graft dysfunction and mortality following lung transplantation.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lung transplantation in 2025: a narrative review of progress, challenges, and the road ahead.Journal of thoracic disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung transplantation (LTx) is a definitive treatment for end-stage lung disease, yet primary graft dysfunction (PGD) remains a major cause of early postoperative morbidity and mortality. Left ventricular diastolic dysfunction (LVDD) is common in these patients, but its impact on PGD and survival remains unclear. This study aimed to determine whether preoperative LVDD increases the risk of PGD and 1-year mortality after LTx. Methods: A retrospective cohort study was conducted, involving 344 patients who underwent LTx in Wuxi People's Hospital from January 1, 2018, to June 22, 2021. Regression models were utilized to examine the effects of LVDD and transthoracic echocardiography (TTE) parameters on PGD or 1-year mortality risk. The predictive performance of various cardiac indicators for PGD was evaluated using the area under the curve (AUC). Results: LVDD [odds ratio (OR) 2.099, 95% confidence interval (CI) 1.071-4.116, P=0.03] and e'<10 cm/s (OR 2.139, 95% CI: 1.177-3.889, P=0.01) were independently associated with a higher risk of PGD. In multivariate analysis, LVDD was not associated with higher 1-year mortality risk (hazard ratio 1.638, 95% CI: 1.129-2.375, P=0.009). The clinical threshold for e' to predict PGD was determined to be 9.85 cm/s, with a sensitivity of 67% and specificity of 48%. Conclusions: Preoperative LVDD significantly increases the risk of PGD following LTx. LVDD was not an independent risk factor for postoperative 1-year mortality. Future prospective clinical studies are required to validate LVDD as a risk factor for post-LTx PGD and to further investigate whether LVDD impacts mortality through mediator effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.